Pivot to Commercialize Cannabis Products in California Under New Regulations
January 03, 2018 04:00 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Jan. 03, 2018 (GLOBE NEWSWIRE) -- via NetworkNewsWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) is pleased to announce that its...
Pivot Initiates Development of Its First Cannabidiol Product with German Technology Partner
December 29, 2017 08:05 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 29, 2017 (GLOBE NEWSWIRE) -- via NetworkNewsWire - Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) is pleased to announce that it has...
Pivot Enters Into Standstill Agreement
December 27, 2017 04:00 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 27, 2017 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) wishes to announce that it has...
Pivot To Enter Legal Cannabis Markets In U.S.
December 22, 2017 09:25 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- via NetworkNewsWire – Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), and its wholly-owned medical...
Pivot Pharma Signs Binding Letter of Intent to Acquire Cannabis Oil Infusion Technology for Use in Food and Beverage Products
December 20, 2017 04:00 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), an emerging biopharmaceutical company, is pleased to...
Pivot Pharmaceuticals To Commence Trading on CSE
December 18, 2017 05:00 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (OTCQB:PVOTF) (“Pivot” or the “Company”), an emerging biopharmaceutical company, is pleased to announce that...
Pivot Pharmaceuticals Acquires BiPhasix™ Transdermal Drug Delivery Technology
September 12, 2017 09:00 ET
|
Pivot Pharmaceuticals Inc.
Vancouver, British Columbia, Sept. 12, 2017 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), is pleased to announce that it has signed a Definitive Agreement...
Pivot Pharmaceuticals Files Application for Canadian Stock Exchange (CSE) Listing
July 12, 2017 09:00 ET
|
Pivot Pharmaceuticals Inc.
BOSTON, MA and VANCOUVER, BC, July 12, 2017 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), a biotechnology company engaged in the development and...
Pivot Pharmaceuticals Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
March 30, 2017 09:00 ET
|
Pivot Pharmaceuticals Inc.
BOSTON, MA and VANCOUVER, BC, March 30, 2017 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), a biotechnology company engaged in the development and...
Pivot Appoints Dr. Pravin Chaturvedi, PhD to Chair Scientific Advisory Board
August 12, 2015 09:00 ET
|
Pivot Pharmaceuticals Inc.
Vancouver, British Columbia, Aug. 12, 2015 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (OTCPK: PVOTF) ("Pivot" or the "Company"), a biotechnology company engaged in the development and...